A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer
Randy F. Sweis, Gurkamal S. Chatta, Rohit K. Jain, Helen Moon, Scott Edward Delacroix, Alana Fang, Leonard D'Amico, Angela Shaulov Kask, Martin A. Cheever, Steven Fling, Elad Sharon, Andreanne Lacroix, Judith C. Kaiser, Russell K. Pachynski, Evan Y. Yu
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer'. Together they form a unique fingerprint.